RUBINSTEIN JULIE
SEC CIK 1780664 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | Pres, COO | 396.8K | — | $14.17M | 37 | 2022-03-04 | 2026-04-27 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-29 19:08 | 2026-04-27 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.46 | +14.7K | 396.8K | +4% | +$124.4K |
| DT | 2026-04-29 19:08 | 2026-04-27 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.23 | -19.0K | 377.8K | -5% | -$270.9K |
| DMT | 2026-04-24 18:29 | 2026-04-22+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.46 | +44.2K | 401.2K | +12% | +$373.6K |
| DMT | 2026-04-24 18:29 | 2026-04-22+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.96 | -57.2K | 382.1K | -13% | -$798.4K |
| DMT | 2026-04-21 18:07 | 2026-04-17+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $9.24 | +56.0K | 426.1K | +15% | +$517.9K |
| DMT | 2026-04-21 18:07 | 2026-04-17+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.60 | -69.1K | 395.1K | -15% | -$1.01M |
| DMT | 2026-04-16 19:36 | 2026-04-14+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.46 | +44.2K | 427.2K | +12% | +$373.6K |
| DMT | 2026-04-16 19:36 | 2026-04-14+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.45 | -57.2K | 408.2K | -12% | -$826.3K |
| DMT | 2026-04-13 19:44 | 2026-04-09+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.45 | +44.2K | 440.2K | +11% | +$329.0K |
| DMT | 2026-04-13 19:44 | 2026-04-09+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.26 | -57.2K | 421.2K | -12% | -$758.1K |
| DMT | 2026-04-08 19:48 | 2026-04-06+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.30 | +56.0K | 465.1K | +14% | +$465.3K |
| DMT | 2026-04-08 19:48 | 2026-04-06+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.34 | -69.1K | 434.2K | -14% | -$990.5K |
| DMT | 2026-04-02 19:16 | 2026-04-01+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.27 | +29.4K | 466.3K | +7% | +$214.1K |
| DMT | 2026-04-02 19:16 | 2026-04-01+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.53 | -38.1K | 447.2K | -8% | -$553.7K |
| DM | 2026-03-31 | 2026-03-27+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.14 | -57.2K | 460.2K | -11% | -$751.3K |
| DM | 2026-03-31 | 2026-03-27+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.27 | +44.2K | 474.9K | +10% | +$321.1K |
| DM | 2026-03-26 | 2026-03-24+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.03 | -57.2K | 473.2K | -11% | -$802.2K |
| DM | 2026-03-26 | 2026-03-24+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $7.27 | +44.2K | 492.3K | +10% | +$321.1K |
| DM | 2026-03-23 | 2026-03-19+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $6.97 | +44.2K | 509.6K | +9% | +$307.7K |
| DM | 2026-03-23 | 2026-03-19+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.46 | -57.2K | 486.2K | -11% | -$769.6K |
| DM | 2026-03-18 | 2026-03-16+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.33 | -57.2K | 503.6K | -10% | -$762.2K |
| DM | 2026-03-18 | 2026-03-16+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $6.55 | +44.2K | 518.3K | +9% | +$289.3K |
| DM | 2026-03-13 | 2026-03-11+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $6.55 | +44.2K | 535.7K | +9% | +$289.3K |
| DM | 2026-03-13 | 2026-03-11+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $13.21 | -179.7K | 517.7K | -26% | -$2.37M |
| DM | 2026-03-10 | 2026-03-06+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $8.53 | +68.3K | 678.8K | +11% | +$582.6K |
| DM | 2026-03-10 | 2026-03-06+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $14.90 | -81.3K | 647.8K | -11% | -$1.21M |
| 2026-03-06 | 2026-03-04 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | A - Grant | $0.00 | +81.2K | 656.5K | +14% | $0 | |
| DM | 2026-03-05 | 2026-03-03+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | M - OptEx | $9.05 | +79.8K | 606.2K | +15% | +$722.0K |
| DM | 2026-03-05 | 2026-03-03+ | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale+OE | $16.09 | -92.8K | 579.6K | -14% | -$1.49M |
| 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | A - Grant | $0.00 | +175.0K | 647.8K | +37% | $0 | |
| M | 2025-03-06 | 2025-03-05 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres, COO | S - Sale | $6.98 | -59.5K | 588.2K | -9% | -$415.5K |
| 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres | A - Grant | $0.00 | +175.0K | 511.8K | +52% | $0 | |
| M | 2024-03-06 | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres | S - Sale | $3.47 | -39.1K | 486.2K | -7% | -$135.8K |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres | A - Grant | $0.00 | +133.0K | 359.5K | +59% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres | S - Sale | $8.57 | -22.7K | 336.8K | -6% | -$194.3K |
| D | 2022-03-08 | 2022-03-07 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres | S - Sale | $12.01 | -4,613 | 226.5K | -2% | -$55.4K |
| D | 2022-03-08 | 2022-03-04 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | Pres | A - Grant | $0.00 | +185.3K | 231.1K | +405% | $0 |
Purchase Sale Sale after option exercise All abbreviations